These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 25488166)

  • 21. Heart rate distribution and predictors of resting heart rate after initiation of beta-blocker treatment in patients with coronary artery disease: REsults of Sympathetic Evaluation And Research of China (RESEARCH) study.
    Zhao YX; Li YP; Gao F; Ma HY; Wang ZJ; Han HY; Shen H; Zhou YJ
    Chin Med J (Engl); 2013; 126(18):3460-3. PubMed ID: 24034090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term stability of heart rate variability in chronic stable angina pectoris, and the impact of an acute myocardial infarction.
    Björkander I; Forslund L; Ericson M; Rehnqvist N; Hjemdahl P; Kahan T
    Clin Physiol Funct Imaging; 2009 May; 29(3):201-8. PubMed ID: 19254330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential effect of β-blockers for heart rate control in coronary artery disease.
    Cordero A; Bertomeu-González V; Mazón P; Moreno-Arribas J; Fácila L; Bueno H; González-Juanatey JR; Bertomeu-Martínez V
    Clin Cardiol; 2011 Dec; 34(12):748-54. PubMed ID: 22083944
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cardioselective beta-adrenoblockers in patients with stable angina pectoris. Comparison of efficacy and safety].
    Dupliakov DV; Glukhova VL; Vozhdaeva ZI; Golovina GA
    Ter Arkh; 2006; 78(9):43-8. PubMed ID: 17076224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. What resting heart rate should one aim for when treating patients with heart failure with a beta-blocker? Experiences from the Metoprolol Controlled Release/Extended Release Randomized Intervention Trial in Chronic Heart Failure (MERIT-HF).
    Gullestad L; Wikstrand J; Deedwania P; Hjalmarson A; Egstrup K; Elkayam U; Gottlieb S; Rashkow A; Wedel H; Bermann G; Kjekshus J;
    J Am Coll Cardiol; 2005 Jan; 45(2):252-9. PubMed ID: 15653024
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduction of resting heart rate with antianginal drugs: review and meta-analysis.
    Cucherat M; Borer JS
    Am J Ther; 2012 Jul; 19(4):269-80. PubMed ID: 21804377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of heart rate in cardiovascular diseases: how the results of the BEAUTIFUL study change clinical practice.
    Bruguera Cortada J; Varela A
    Am J Cardiovasc Drugs; 2009; 9 Suppl 1():9-12. PubMed ID: 20000882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of anginal symptoms and myocardial ischemia and their effect on clinical outcomes in outpatients with stable coronary artery disease: data from the International Observational CLARIFY Registry.
    Steg PG; Greenlaw N; Tendera M; Tardif JC; Ferrari R; Al-Zaibag M; Dorian P; Hu D; Shalnova S; Sokn FJ; Ford I; Fox KM;
    JAMA Intern Med; 2014 Oct; 174(10):1651-9. PubMed ID: 25110899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heart rate-guided, but not dose-guided titration of beta blockers stabilizes ventricular repolarization in patients with chronic heart failure.
    Fister M; Mikuz U; Starc V; Vrtovec B; Haddad F
    J Electrocardiol; 2016; 49(4):579-86. PubMed ID: 26875428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ivabradine: beyond heart rate control.
    Riccioni G; Vitulano N; D'Orazio N
    Adv Ther; 2009 Jan; 26(1):12-24. PubMed ID: 19165437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of resting heart rate and clinical characteristics in outpatients with stable coronary artery disease in Turkey: PULSE study.
    Ergene O; Akyildiz ZI;
    Cardiol J; 2014; 21(4):378-83. PubMed ID: 24146273
    [TBL] [Abstract][Full Text] [Related]  

  • 32. β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease.
    Bangalore S; Steg G; Deedwania P; Crowley K; Eagle KA; Goto S; Ohman EM; Cannon CP; Smith SC; Zeymer U; Hoffman EB; Messerli FH; Bhatt DL;
    JAMA; 2012 Oct; 308(13):1340-9. PubMed ID: 23032550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ivabradine improves quality of life in subjects with chronic heart failure compared to treatment with β-blockers: results of a multicentric observational APULIA study.
    Riccioni G; Masciocco L; Benvenuto A; Saracino P; De Viti D; Massari F; Meliota G; Buta F; Speziale G
    Pharmacology; 2013; 92(5-6):276-80. PubMed ID: 24296869
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of effectiveness of carvedilol versus bisoprolol for prevention of postdischarge atrial fibrillation after coronary artery bypass grafting in patients with heart failure.
    Marazzi G; Iellamo F; Volterrani M; Caminiti G; Madonna M; Arisi G; Massaro R; Righi D; Rosano GM
    Am J Cardiol; 2011 Jan; 107(2):215-9. PubMed ID: 21129714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacotherapy in patients with stable coronary artery disease treated on an outpatient basis in Poland. Results of the multicentre RECENT study.
    Banasiak W; Wilkins A; Pociupany R; Ponikowski P
    Kardiol Pol; 2008 Jun; 66(6):642-9; discussion 650. PubMed ID: 18626833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of an acute coronary syndrome pathway in achieving target heart rate and utilization of evidence-based doses of beta-blockers.
    Irani F; Herial N; Colyer WR
    Am J Ther; 2012 Nov; 19(6):397-402. PubMed ID: 21317621
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of outpatients in France with stable coronary artery disease. Findings from the prospeCtive observational LongitudinAl RegIstry oF patients with stable coronary arterY disease (CLARIFY) registry.
    Danchin N; Ferrieres J; Guenoun M; Cattan S; Rushton-Smith SK; Greenlaw N; Ferrari R; Steg PG;
    Arch Cardiovasc Dis; 2014; 107(8-9):452-61. PubMed ID: 25128934
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discharge heart rate and β-blocker dose in patients hospitalized with heart failure: Findings from the OPTIMIZE-HF registry.
    DeVore AD; Mi X; Mentz RJ; Fonarow GC; Van Dyke MK; Maya JF; Hardy NC; Hammill BG; Hernandez AF
    Am Heart J; 2016 Mar; 173():172-8. PubMed ID: 26920611
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sex Differences in Cardiac Medication Use Post-Catheterization in Patients Undergoing Coronary Angiography for Stable Angina with Nonobstructive Coronary Artery Disease.
    Galway S; Adatia F; Grubisic M; Lee M; Daniele P; Humphries KH; Sedlak TL
    J Womens Health (Larchmt); 2017 Sep; 26(9):976-983. PubMed ID: 28384013
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Occurrence of composite cardiac endpoints with change in resting heart rate among Chinese patients with coronary artery disease: Chinese cohort from the real-world BISO-CAD study.
    Chen Y; Yang X; Huang S; Fu G; Chen X; Yang Y; Liu S; Xu H; Ma T; Zhou X; Lv Z; Yang M; Gan X; Xu D; Cao F; Liu H; Li J; Zheng Q; Wang N; Yuan Y; Liu W; Yang T
    Curr Med Res Opin; 2018 Nov; 34(11):1921-1926. PubMed ID: 29557206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.